Munani Pharmaceuticals Private Limited
About Munani Pharmaceuticals Private Limited
Data last updated:
Munani Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It was incorporated on 12 June 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2023PTC404911.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Krutik Arvind Munani (Managing Director) and Priyanshi Krutik Munani (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.75 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹20.53 Lakh (net margin 3%) and EBITDA of ₹42.29 Lakh (EBITDA margin 6.3%).
The company is associated with 1 brand: Munani Pharmaceuticals.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address6 Floor – 1 Plot – 79, Devkaran Mansion Block – 1, Mumbai, Maharashtra, India – 400002
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals operates one associated brand: Munani Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Exports and distributes specialty medicines, life-saving drugs globally. | munanipharma.com |
Business Activity of Munani Pharmaceuticals Private Limited
The main business activity of Munani Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Munani Pharmaceuticals Private Limited FY 2025 filings available
Munani Pharmaceuticals Private Limited reported revenue of ₹6.75 Cr (up 471% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Munani Pharmaceuticals Private Limited
Revenue rose 471% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Munani Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹42.29 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹20.53 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Munani Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 6.3% | •••• |
| Net Profit Margin | 3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Munani Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krutik Arvind Munani Also directs: Gemini Healthworld LLP | Managing Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Priyanshi Krutik Munani Also directs: Gemini Healthworld LLP | Managing Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Sarojben Arvindkumar Munani | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Arvindkumar Jawaji Munani | Director | 12 Jun 2023 | 3 Years 4 Months | Current |
Peer Comparison of Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexicon Pharmaceuticals Private Limited | ₹6.83 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Nashik, Maharashtra, India |
| Candaur Pharmaceuticals Private Limited | ₹6.79 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Thane, Maharashtra, India |
| Gliesse Pharmaceuticals Private Limited | ₹6.78 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| Sanora Pharmaceuticals Private Limited | ₹6.77 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Ambernath East, Maharashtra, India |
| Munani Pharmaceuticals Private Limited this company | ₹6.75 Cr (FY 2025) | •••• | •••• | 471.0% | •••• | Mumbai, Maharashtra, India |
| Renocis Pharmaceuticals Private Limited | ₹6.74 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Jaipur, Rajasthan, India |
| Samnova Pharmaceuticals Private Limited | ₹6.74 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Ahmedabad, Gujarat, India |
| Pharind Pharmaceuticals Private Limited | ₹6.72 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Sorbax Pharmaceuticals Private Limited | ₹6.71 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Baddi, Himachal Pradesh, India |
| TPPL Pharmaceuticals Private Limited | ₹6.69 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Munani Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Munani Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Munani Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Arvindkumar Jawaji Munani was appointed as Director on 12 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Munani Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Munani Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Munani Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Munani Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Munani Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Munani Pharmaceuticals Private Limited
Munani Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. It was incorporated on 12 June 2023 (3+ years old) and is registered under CIN U46497MH2023PTC404911.
Munani Pharmaceuticals reported revenue of ₹6.75 Cr for FY 2025 (up 471% YoY).
Munani Pharmaceuticals has 4 current directors:
- Krutik Arvind Munani - Managing Director
- Priyanshi Krutik Munani - Managing Director
- Sarojben Arvindkumar Munani - Director
- Arvindkumar Jawaji Munani - Director
Munani Pharmaceuticals reported a net profit of ₹20.53 Lakh (net margin 3%) and EBITDA of ₹42.29 Lakh (EBITDA margin 6.3%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Munani Pharmaceuticals is U46497MH2023PTC404911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Munani Pharmaceuticals was incorporated on 12 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Munani Pharmaceuticals by revenue are Nexicon Pharmaceuticals Private Limited, Candaur Pharmaceuticals Private Limited, Gliesse Pharmaceuticals Private Limited, Sanora Pharmaceuticals Private Limited, Anant Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arvindkumar Jawaji Munani was appointed as Director on 12 Jun 2023. Krutik Arvind Munani was appointed as Managing Director on 12 Jun 2023. Priyanshi Krutik Munani was appointed as Managing Director on 12 Jun 2023. Munani Pharmaceuticals has 4 board changes on record in total.
The registered office of Munani Pharmaceuticals is at 6 Floor – 1 Plot – 79, Devkaran Mansion Block – 1, Mumbai, Maharashtra, India – 400002.
Munani Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
No. Munani Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.